We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

132 hedge funds and large institutions have $1.08B invested in Enfusion, Inc. in 2025 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 29 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 29

50% more call options, than puts

Call options by funds: $521K | Put options by funds: $348K

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

16% more capital invested

Capital invested by funds: $939M → $1.08B (+$146M)

0% more funds holding

Funds holding: 132132 (0)

0% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 39

Holders
132
Holders Change
Holders Change %
0%
% of All Funds
1.77%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.09%
New
39
Increased
51
Reduced
29
Closed
39
Calls
$521K
Puts
$348K
Net Calls
+$173K
Net Calls Change
-$994K
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$4.85M -$88.2K -7,975 -2%
WIC
27
Water Island Capital
New York
$4.73M +$4.69M +424,031 New
SAM
28
Silvercrest Asset Management
New York
$4.63M -$26.5K -2,393 -0.6%
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
$4.48M +$1.92M +174,036 +76%
Charles Schwab
30
Charles Schwab
California
$4.15M +$12.2K +1,101 +0.3%
WCMNY
31
Westchester Capital Management (New York)
New York
$4.08M +$4.05M +366,100 New
Renaissance Technologies
32
Renaissance Technologies
New York
$3.74M +$1.84M +166,581 +99%
NYLIM
33
New York Life Investment Management
New York
$3.67M +$3.64M +329,008 New
Morgan Stanley
34
Morgan Stanley
New York
$3.15M -$2.64M -238,693 -46%
HF
35
HRT Financial
New York
$2.87M +$2.12M +191,726 +294%
PCM
36
Prelude Capital Management
New York
$2.85M +$2.83M +255,622 New
Lazard Asset Management
37
Lazard Asset Management
New York
$2.85M +$1.34M +121,355 +90%
Toronto Dominion Bank
38
Toronto Dominion Bank
Ontario, Canada
$2.67M +$2.65M +239,339 New
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$2.6M +$1.52M +137,907 +144%
OR
40
Olympiad Research
Connecticut
$2.5M +$2.48M +224,012 New
Squarepoint
41
Squarepoint
New York
$1.85M +$1.44M +130,637 +367%
OAC
42
OMERS Administration Corp
Ontario, Canada
$1.81M +$1.8M +162,400 New
Goldman Sachs
43
Goldman Sachs
New York
$1.63M -$516K -46,690 -24%
Citigroup
44
Citigroup
New York
$1.58M +$1.06M +95,938 +210%
BCM
45
BCK Capital Management
Connecticut
$1.47M +$1.46M +132,000 New
HM
46
Harvest Management
New York
$1.44M +$1.43M +129,400 New
JP Morgan Chase
47
JP Morgan Chase
New York
$1.41M -$1.95M -176,639 -58%
Bank of New York Mellon
48
Bank of New York Mellon
New York
$1.39M -$21K -1,900 -2%
Credit Agricole
49
Credit Agricole
France
$1.29M +$1.28M +116,045 New
CP
50
CenterBook Partners
Connecticut
$1.29M +$1.28M +115,431 New

ENFN Hedge Fund Activity: Q1 2025 in Review

132 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q1 2025, worth a combined $1.08B — up 16% from $939M a quarter earlier.

Fund positioning in ENFN was balanced in Q1 2025: 39 funds opened new positions, 39 closed out, 51 added to existing stakes and 29 trimmed.

The largest buyer was Alpine Associates Management, opening a new position worth an estimated $26.9M. The largest seller was Brown Capital Management, cutting an estimated $22.2M.

  • 132 institutional investors held Enfusion, Inc. (ENFN) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $1.08B of Enfusion, Inc. stock for Q1 2025, up 16% quarter-over-quarter.
  • 39 funds opened new Enfusion, Inc. positions in Q1 2025 and 39 closed out, a net change of 0 holders.
  • The largest Enfusion, Inc. buyer in Q1 2025 was Alpine Associates Management, an estimated $26.9M added.
  • The largest Enfusion, Inc. seller in Q1 2025 was Brown Capital Management, an estimated $22.2M sold.

Based on aggregated 13F filings for Q1 2025.